Get started
Author

J.P. Clancy

Glucocorticoid treatment decreases muscarinic receptor expression in canine airway smooth muscle
1997 · C. W. Emala, J. Clancy, et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 52
MgSO4 relaxes porcine airway smooth muscle by reducing Ca2+ entry
1996 · D. Kumasaka, K. S. Lindeman, et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 22
Clinical evaluation of VX-809, a novel investigational oral F508del-CFTR corrector, in subjects with cystic fibrosis homozygous for the F508del–CFTR mutation
2010 · J.P. Clancy, G. Spencer-Green · Journal of Cystic Fibrosis · 13
Parallel effects of VX-770 on transepithelial potential difference in vitro and in vivo
2010 · S.M. Rowe, J.P. Clancy, et al. · Journal of Cystic Fibrosis · 8
PDF
Genetic and Reproductive Knowledge Among Adolescents and Adults With Cystic Fibrosis
2008 · Grace H. Houser, Cheryl L. Holt, et al. · CHEST Journal · 8
PDF
Chronic carbachol pretreatment decreases adenylyl cyclase activity in airway smooth muscle
1997 · G. Schears, J. Clancy, et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 7
EPS1.3 Safety, tolerability and early signs of efficacy with riociguat for the treatment of adult Phe508del homozygous cystic fibrosis patients: study design and rationale for the Rio-CF study
2017 · N. Derichs, J. Taylor-Cousar, et al. · Journal of Cystic Fibrosis · 5
PDF
WS7.3 Once-daily liposomal amikacin for inhalation is noninferior to twice-daily tobramycin inhalation solution in improving pulmonary function in cystic fibrosis patients with chronic infection due to Pseudomonas aeruginosa
2014 · D. Bilton, T. Pressler, et al. · Journal of Cystic Fibrosis · 5
PDF
Diagnosing cystic fibrosis in patients with non-diagnostic results: the case for intestinal current measurements
2010 · J. P. Clancy · Thorax · 4
PDF
Final results of a 14- and 28-day study of VX-770 in subjects with CF
2009 · F.J. Accurso, S.M. Rowe, et al. · Journal of Cystic Fibrosis · 4
PDF
112 Analysis of long-term use of liposomal amikacin for inhalation (LAI) in patients with cystic fibrosis (CF) who have chronic infection from Pseudomonas aeruginosa
2015 · D. Bilton, T. Pressler, et al. · Journal of Cystic Fibrosis · 3
PDF
Neutrophil Extracellular Trap Burden in CF and Disease Control BAL
2020 · K.M. Hudock, M. Imbrogno, et al. · 2
WS13.1 QR-010, an investigational RNA therapeutic, improves CFTR activity in cystic fibrosis subjects homozygous for the F508del mutation
2017 · S. Rowe, I. Sermet-Gaudelus, et al. · Journal of Cystic Fibrosis · 2
Cationic Liposomes for Gene Therapy Applications
1999 · J.P. Clancy, Eric S. Sorscher · 2
P090 Treatment use among SIMPLIFY trial participants through 24 weeks of follow-up
2023 · A.H. Gifford, K. Odem-Davis, et al. · Journal of Cystic Fibrosis · 1
PDF
43: Monitoring and phenotyping rapid cystic fibrosis disease progression using community characteristics and environmental exposures
2021 · A. Palipana, E. Gecili, et al. · Journal of Cystic Fibrosis · 1
PDF
Improvement in ion transport biomarkers and spirometry with the investigational CFTR potentiator VX-770 in subjects with cystic fibrosis and the G551D-CFTR mutation
2010 · S.M. Rowe, F.J. Accurso, et al. · Paediatric Respiratory Reviews · 1
In vivo glucocorticoids decrease expression of muscarinic receptors in airway smooth muscle
1997 · C.W. Emala, J. Clancy, et al. · Life Sciences · 1
57: Secular drift in predictive accuracy of pulmonary exacerbations: A registry study
2021 · Z. Wang, G. Zhou, et al. · Journal of Cystic Fibrosis
PDF
378: CF mouse airway smooth muscle in advanced age and allergic asthma
2021 · E. Kramer, K. Hudock, et al. · Journal of Cystic Fibrosis
PDF
322: Communities of color provide insights about engagement barriers
2021 · J. Hudson, J. Green, et al. · Journal of Cystic Fibrosis
PDF
34: Predicting declines in lung function with the U.S. CF registry: Impact of initiating highly effective modulator therapy
2021 · G. Zhou, Z. Wang, et al. · Journal of Cystic Fibrosis
PDF
33: Hypertonic saline withdraw in CF patients while on ivacaftor: An analysis of the CF Foundation Patient Registry (CFFPR)
2021 · B. Huang, C. Chen, et al. · Journal of Cystic Fibrosis
PDF
578: Serum biomarkers identified by proteomics and measured by commercially available assays associated with lung function during clinically stable states
2021 · R. Szczesniak, S. Heltshe, et al. · Journal of Cystic Fibrosis
PDF
588: Insights into and input on genetic-based therapies and clinical trials by the cystic fibrosis community
2021 · E. Aliaj, J. Hudson, et al. · Journal of Cystic Fibrosis
PDF
Works count: 31
Citation count: 141
H-index: 6
I10-index: 3
Year
Topic
Type